Preclinical efficacy of the bioreductive alkylating agent RH1 against paediatric tumours.

Br J Cancer · 2009 · PMC2713707 · PMID 19491903

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

verged on significanceP =0.057so close (0.05 < p ≤ 0.1)

The difference in tumour growth in RH1- vs vehicle-treated mice across the two tumour types verged on significance ( P =0.057) ( Figure 5C ).

also in 15 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.